These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35691019)

  • 21. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
    Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
    Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
    Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
    Baghdasaryan A; Claudel T; Kosters A; Gumhold J; Silbert D; Thüringer A; Leski K; Fickert P; Karpen SJ; Trauner M
    Gut; 2010 Apr; 59(4):521-30. PubMed ID: 20332524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.
    Hintermann E; Tondello C; Fuchs S; Bayer M; Pfeilschifter JM; Taubert R; Mollenhauer M; Elferink RPJO; Manns MP; Christen U
    J Autoimmun; 2024 Jun; 146():103229. PubMed ID: 38653165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis.
    Liu T; Wang RX; Han J; Li ZD; Sheps JA; Zheng LJ; Xu XX; Ling V; Wang JS
    J Clin Transl Hepatol; 2024 Feb; 12(2):151-161. PubMed ID: 38343606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
    Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
    J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
    Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
    Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
    Stiedl P; McMahon R; Blaas L; Stanek V; Svinka J; Grabner B; Zollner G; Kessler SM; Claudel T; Müller M; Mikulits W; Bilban M; Esterbauer H; Eferl R; Haybaeck J; Trauner M; Casanova E
    Hepatology; 2015 Feb; 61(2):613-26. PubMed ID: 25179284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4
    Krishnan A; Katsumi T; Guicciardi ME; Azad AI; Ozturk NB; Trussoni CE; Gores GJ
    Am J Pathol; 2020 Jun; 190(6):1284-1297. PubMed ID: 32240619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.
    Miethke AG; Zhang W; Simmons J; Taylor AE; Shi T; Shanmukhappa SK; Karns R; White S; Jegga AG; Lages CS; Nkinin S; Keller BT; Setchell KD
    Hepatology; 2016 Feb; 63(2):512-23. PubMed ID: 26172874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
    Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
    Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
    J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
    Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
    J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
    Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
    J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.
    Azad AI; Krishnan A; Troop L; Li Y; Katsumi T; Pavelko K; Kostallari E; Guicciardi ME; Gores GJ
    Hepatology; 2020 Sep; 72(3):1013-1028. PubMed ID: 32128842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.